Russell P Beyer is Chief Financial Officer of SAB Biotherapeutics, Inc.. Currently has a direct ownership of 2,475 shares of SABS, which is worth approximately $9,875. The most recent transaction as insider was on Oct 18, 2021, when has been sold 2,475 shares (Common Stock) at a price of $10.1 per share, resulting in proceeds of $24,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.48K
0% 3M change
0% 12M change
Total Value Held $9,875

Russell P Beyer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 18 2021
BUY
Grant, award, or other acquisition
$24,998 $10.1 p/Share
2,475 Added 50.0%
2,475 Common Stock
RPB

Russell P Beyer

Chief Financial Officer
Sioux Falls, SD

Track Institutional and Insider Activities on SABS

Follow SAB Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SABS shares.

Notify only if

Insider Trading

Get notified when an Sab Biotherapeutics, Inc. insider buys or sells SABS shares.

Notify only if

News

Receive news related to SAB Biotherapeutics, Inc.

Track Activities on SABS